摘要
目的观察云南白药联合依达拉奉治疗急性脑出血的临床疗效。方法将60例急性脑出血患者随机分成对照组和治疗组,每组30例,对照组给予常规治疗,治疗组在常规治疗的基础上,给予云南白药联合依达拉奉治疗,比较两组治疗前后的血肿体积,神经功能缺损评分及总有效率。结果治疗前后对比,治疗后两组的头颅CT血肿体积及神经功能缺损评分均降低(P<0.01);治疗后治疗组的血肿体积及神经功能缺损评分均明显低于对照组(P<0.05),治疗组总有效率86.7%,对照组总有效率73.3%,治疗组高于对照组,未出现严重的不良反应。结论云南白药联合依达拉奉治疗急性脑出血,可显著促进患者脑血肿吸收,改善神经功能缺损,安全有效。
Objective To observe the clinical efficacy on treatment of acute cerebral hemorrhage with Yunnan baiyao combined with edaravone.Methods 60 patients with acute cerebral hemorrhage were randomly divided into control group and treatment group,30 cases in each group,the control group was given conventional treatment,the treatment group was given Yunnan Baiyao combined with edaravone treatment on the basis of conventional therapy,compared the hematoma volume,neurological function deficit scores and the total efficiency in two groups before and after treatment. Results Compared before and after treatment,cranial CT hematoma volume and neurological deficit score were decreased after treatment in two groups（P 〈 0.01）; after treatment,the hematoma volume and neurogical deficit score were significantly lower than those in the control group（P 〈 0.05）,the total effectiveness in treatment group was 86.7%,the total effectiveness in control group was 73.3%,the treatment group higher than that in control group,without serious adverse reactions oceuring. Conclusion Yunnanbaiyao combined with edaravone in treatment of acute cerebral hemorrhage,can significantly promote the absorption of cerebral hematoma,improve nerve function deficit,safe and effective.
出处
《中国医药科学》
2013年第11期82-83,共2页
China Medicine And Pharmacy
关键词
云南白药
依达拉奉
急性脑出血
Yunnanbaiyao
Edaravone
Acute cerebral hemorrhage
